Physician profile
Robert Abouassaly
NPI 1285804526
$2,397.78
in general payments reported to CMS, 2019-2025
12 companies · $942 in 2025
The $942 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.54 · 2021: $422 · 2022: $46.39 · 2023: $869 · 2024: $28.91 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021 · Travel and Lodging: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.34 |
| Travel and Lodging | $818.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $942.41 | 2025 | |
| Intuitive Surgical, INC. | $851.83 | 2023 | Da Vinci Surgical System |
| Angiodynamics, INC. | $204.62 | 2021 | |
| Siemens Medical Solutions USA, INC. | $136.41 | 2021 | |
| Teleflex LLC | $80.76 | 2021 | |
| Janssen Biotech, INC. | $45.56 | 2019 | |
| Boston Scientific Corporation | $28.91 | 2024 | Ams 700 |
| Abbvie INC. | $27.00 | 2022 | |
| Rochester Medical Corporation | $23.89 | 2019 | |
| Biogen, INC. | $20.09 | 2019 | |
| Koelis INC. | $19.39 | 2022 | |
| Axonics, INC. | $16.91 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Abouassaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.